Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Antibiotic resistance: The challenges and some emerging strategies for tackling a global menaceJournal of clinical laboratory analysis, 2022-09, Vol.36 (9), p.e24655-n/a [Peer Reviewed Journal]2022 The Authors. published by Wiley Periodicals LLC. ;2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0887-8013 ;EISSN: 1098-2825 ;DOI: 10.1002/jcla.24655 ;PMID: 35949048Full text available |
|
2 |
Material Type: Article
|
Alzheimer's disease drug development pipeline: 2020Alzheimer's & dementia : translational research & clinical interventions, 2020, Vol.6 (1), p.e12050-n/a [Peer Reviewed Journal]2020 The Authors. published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association. ;2020 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association. ;2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2352-8737 ;EISSN: 2352-8737 ;DOI: 10.1002/trc2.12050 ;PMID: 32695874Full text available |
|
3 |
Material Type: Article
|
Alzheimer's disease drug development pipeline: 2021Alzheimer's & dementia : translational research & clinical interventions, 2021, Vol.7 (1), p.e12179-n/a [Peer Reviewed Journal]2021 The Authors. published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association. ;2021 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association. ;2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2352-8737 ;EISSN: 2352-8737 ;DOI: 10.1002/trc2.12179 ;PMID: 34095440Full text available |
|
4 |
Material Type: Article
|
Alzheimer's disease drug development pipeline: 2022Alzheimer's & dementia : translational research & clinical interventions, 2022, Vol.8 (1), p.e12295-n/a [Peer Reviewed Journal]2022 The Authors. published by Wiley Periodicals, LLC on behalf of Alzheimer's Association ;2022 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2352-8737 ;EISSN: 2352-8737 ;DOI: 10.1002/trc2.12295 ;PMID: 35516416Full text available |
|
5 |
Material Type: Article
|
Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal productsEMBO molecular medicine, 2017-06, Vol.9 (6), p.737-740 [Peer Reviewed Journal]2017 The Authors. Published under the terms of the CC BY 4.0 license ;COPYRIGHT 2017 John Wiley & Sons, Inc. ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201707573 ;PMID: 28396566Full text available |
|
6 |
Material Type: Article
|
Radiotherapy–immunotherapy combinations – perspectives and challengesMolecular oncology, 2020-07, Vol.14 (7), p.1529-1537 [Peer Reviewed Journal]2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. ;COPYRIGHT 2020 John Wiley & Sons, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;ISSN: 1574-7891 ;EISSN: 1878-0261 ;DOI: 10.1002/1878-0261.12658 ;PMID: 32112478Full text available |
|
7 |
Material Type: Article
|
Multifocal Polypseudophakia With Rayner Sulcoflex Trifocal and In-the-Bag Alcon PanOptix Diffractive Trifocal Intraocular Lenses: A Case ReportJournal of refractive surgery (1995), 2023-11, Vol.3 (4), p.E53-e55 [Peer Reviewed Journal]COPYRIGHT 2023 Slack, Inc. ;This work is published under https://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2768-1599 ;ISSN: 1081-597X ;EISSN: 2768-1599 ;EISSN: 1938-2391 ;DOI: 10.3928/jrscr-20231024-01Full text available |
|
8 |
Material Type: Article
|
Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysisOpen forum infectious diseases, 2022-07, Vol.9 (7), p.ofac300-ofac300 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2022 ;COPYRIGHT 2022 Oxford University Press ;ISSN: 2328-8957 ;EISSN: 2328-8957 ;DOI: 10.1093/ofid/ofac300 ;PMID: 35873302Full text available |
|
9 |
Material Type: Article
|
Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and SafetyOpen forum infectious diseases, 2019-01, Vol.6 (1), p.ofy331 [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2018 ;COPYRIGHT 2019 Oxford University Press ;ISSN: 2328-8957 ;EISSN: 2328-8957 ;DOI: 10.1093/ofid/ofy331 ;PMID: 30648126Full text available |
|
10 |
Material Type: Article
|
ITP-Pred: an interpretable method for predicting, therapeutic peptides with fused features low-dimension representationBriefings in bioinformatics, 2021-07, Vol.22 (4) [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2020 ;The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com ;ISSN: 1467-5463 ;EISSN: 1477-4054 ;DOI: 10.1093/bib/bbaa367 ;PMID: 33313672Full text available |
|
11 |
Material Type: Article
|
Machine learning for synergistic network pharmacology: a comprehensive overviewBriefings in bioinformatics, 2023-05, Vol.24 (3) [Peer Reviewed Journal]The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2023 ;The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com ;ISSN: 1467-5463 ;EISSN: 1477-4054 ;DOI: 10.1093/bib/bbad120 ;PMID: 37031957Full text available |
|
12 |
Material Type: Article
|
Alzheimer's disease drug development pipeline: 2023Alzheimer's & dementia : translational research & clinical interventions, 2023-04, Vol.9 (2), p.e12385-n/a [Peer Reviewed Journal]2023 The Authors. published by Wiley Periodicals LLC on behalf of Alzheimer's Association. ;2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2352-8737 ;EISSN: 2352-8737 ;DOI: 10.1002/trc2.12385 ;PMID: 37251912Full text available |
|
13 |
Material Type: Article
|
Molecular basis for Poria cocos mushroom polysaccharide used as an antitumour drug in ChinaJournal of cellular and molecular medicine, 2019-01, Vol.23 (1), p.4-20 [Peer Reviewed Journal]2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.13564 ;PMID: 30444050Full text available |
|
14 |
Material Type: Article
|
Tamiflu, clinical trials and the Public Accounts CommitteePrescriber (London, England), 2014-06, Vol.25 (11), p.28-29 [Peer Reviewed Journal]Copyright © 2014 Wiley Interface Ltd ;ISSN: 0959-6682 ;EISSN: 1931-2253 ;DOI: 10.1002/psb.1214Full text available |
|
15 |
Material Type: Article
|
Health system efficiency in Germany: results of a pilot study to assess health system performanceEuropean journal of public health, 2022-10, Vol.32 (Supplement_3) [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. 2022 ;The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. ;ISSN: 1101-1262 ;EISSN: 1464-360X ;DOI: 10.1093/eurpub/ckac131.024Full text available |
|
16 |
Material Type: Article
|
5.M. Workshop: The need to account for vaccine-specificities in the implementation of the EU Regulation on HTAEuropean journal of public health, 2022-10, Vol.32 (Supplement_3) [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. 2022 ;The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. ;ISSN: 1101-1262 ;EISSN: 1464-360X ;DOI: 10.1093/eurpub/ckac129.326Full text available |
|
17 |
Material Type: Article
|
Coronavirus Disease 2019–Associated Invasive Fungal InfectionOpen forum infectious diseases, 2021-12, Vol.8 (12), p.ofab510-ofab510 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2021 ;COPYRIGHT 2021 Oxford University Press ;ISSN: 2328-8957 ;EISSN: 2328-8957 ;DOI: 10.1093/ofid/ofab510 ;PMID: 34877364Full text available |
|
18 |
Material Type: Article
|
Rhamnolipids produced by Pseudomonas: from molecular genetics to the marketMicrobial biotechnology, 2021-01, Vol.14 (1), p.136-146 [Peer Reviewed Journal]2020 The Authors. published by John Wiley & Sons Ltd and Society for Applied Microbiology. ;2020 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology. ;2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1751-7915 ;EISSN: 1751-7915 ;DOI: 10.1111/1751-7915.13700 ;PMID: 33151628Full text available |
|
19 |
Material Type: Article
|
Public preference for COVID‐19 vaccines in China: A discrete choice experimentHealth expectations : an international journal of public participation in health care and health policy, 2020-12, Vol.23 (6), p.1543-1578 [Peer Reviewed Journal]2020 The Authors published by John Wiley & Sons Ltd ;2020 The Authors Health Expectations published by John Wiley & Sons Ltd. ;COPYRIGHT 2020 John Wiley & Sons, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1369-6513 ;EISSN: 1369-7625 ;DOI: 10.1111/hex.13140 ;PMID: 33022806Full text available |
|
20 |
Material Type: Article
|
Biochemistry, genetics and biotechnology of glycerol utilization in Pseudomonas speciesMicrobial biotechnology, 2020-01, Vol.13 (1), p.32-53 [Peer Reviewed Journal]2019 The Authors. published by John Wiley & Sons Ltd and Society for Applied Microbiology. ;2019 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1751-7915 ;EISSN: 1751-7915 ;DOI: 10.1111/1751-7915.13400 ;PMID: 30883020Full text available |